232 related articles for article (PubMed ID: 25395468)
1. Steroid-induced scleroderma renal crisis in an at-risk patient.
Toescu SM; Mansell A; Dinneen E; Persey M
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25395468
[TBL] [Abstract][Full Text] [Related]
2. Late-onset scleroderma renal crisis induced by tacrolimus and prednisolone: a case report.
Nunokawa T; Akazawa M; Yokogawa N; Shimada K; Hiramatsu K; Nishio Y; Sugii S
Am J Ther; 2014; 21(5):e130-3. PubMed ID: 22836123
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis.
Gordon SM; Stitt RS; Nee R; Bailey WT; Little DJ; Knight KR; Hughes JB; Edison JD; Olson SW
J Rheumatol; 2019 Jan; 46(1):85-92. PubMed ID: 30008456
[TBL] [Abstract][Full Text] [Related]
4. Scleroderma renal crisis and cancer.
Crosnier C; Achille A; Lecouffe-Desprets M; Néel A; Durant C; Agard C
QJM; 2018 Apr; 111(4):261-262. PubMed ID: 29346637
[No Abstract] [Full Text] [Related]
5. [A retrospective clinical analysis of 16 patients with scleroderma renal crisis].
Zhou J; Xu D; Hou Y; Wang Q; Li M; Zeng X
Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):125-9. PubMed ID: 25907843
[TBL] [Abstract][Full Text] [Related]
6. Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor.
Hesselstrand R; Scheja A; Wuttge DM
Scand J Rheumatol; 2012 Feb; 41(1):39-43. PubMed ID: 22044051
[TBL] [Abstract][Full Text] [Related]
7. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and outcome of Thai patients with scleroderma renal crisis: a disease duration-matched case control study.
Wangkaew S; Lertthanaphok S; Puntana S; Noppakun K
Int J Rheum Dis; 2017 Oct; 20(10):1562-1571. PubMed ID: 28752678
[TBL] [Abstract][Full Text] [Related]
9. Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis in the absence of skin disease.
Bhavsar SV; Carmona R
J Clin Rheumatol; 2014 Oct; 20(7):379-82. PubMed ID: 25275766
[TBL] [Abstract][Full Text] [Related]
10. Renal function is mostly preserved in patients with systemic sclerosis.
Scheja A; Bartosik I; Wuttge DM; Hesselstrand R
Scand J Rheumatol; 2009; 38(4):295-8. PubMed ID: 19214870
[TBL] [Abstract][Full Text] [Related]
11. [Scleroderma renal crisis].
Morović-Vergles J; Culo MI; Kaliterna DM
Reumatizam; 2010; 57(2):109-11. PubMed ID: 21875014
[TBL] [Abstract][Full Text] [Related]
12. Arterial hypertension treated with angiotensin converting enzyme inhibitors and glucocorticoids are independent risk factors associated with decreased glomerular filtration rate in systemic sclerosis.
Ostojic P; Stojanovski N
Rheumatol Int; 2017 Mar; 37(3):363-368. PubMed ID: 28008457
[TBL] [Abstract][Full Text] [Related]
13. Scleroderma renal crisis.
Mouthon L; Bussone G; Berezné A; Noël LH; Guillevin L
J Rheumatol; 2014 Jun; 41(6):1040-8. PubMed ID: 24833760
[TBL] [Abstract][Full Text] [Related]
14. Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management.
Shanmugam VK; Steen VD
Curr Opin Rheumatol; 2012 Nov; 24(6):669-76. PubMed ID: 22955019
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroids and the risk of scleroderma renal crisis: a systematic review.
Trang G; Steele R; Baron M; Hudson M
Rheumatol Int; 2012 Mar; 32(3):645-53. PubMed ID: 21132302
[TBL] [Abstract][Full Text] [Related]
16. Scleroderma renal crisis precipitated by steroid treatment in systemic lupus erythematosus and scleroderma overlap syndrome.
Alayoud A; Qamouss O; Hamzi A; Benyahia M; Oualim Z
Arab J Nephrol Transplant; 2012 Sep; 5(3):153-7. PubMed ID: 22967254
[TBL] [Abstract][Full Text] [Related]
17. Scleroderma renal crisis: a rare but severe complication of systemic sclerosis.
Mouthon L; Bérezné A; Bussone G; Noël LH; Villiger PM; Guillevin L
Clin Rev Allergy Immunol; 2011 Apr; 40(2):84-91. PubMed ID: 20012923
[TBL] [Abstract][Full Text] [Related]
18. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.
Teixeira L; Mouthon L; Mahr A; Berezné A; Agard C; Mehrenberger M; Noël LH; Trolliet P; Frances C; Cabane J; Guillevin L;
Ann Rheum Dis; 2008 Jan; 67(1):110-6. PubMed ID: 17557890
[TBL] [Abstract][Full Text] [Related]
19. A case of renal crisis in a Korean scleroderma patient with anti-RNA polymerase I and III antibodies.
Kang EH; Im CH; Kim SH; Chung JR; Lee EY; Kim DJ; Lee EB; Song YW
J Korean Med Sci; 2006 Dec; 21(6):1121-3. PubMed ID: 17179700
[TBL] [Abstract][Full Text] [Related]
20. Serologic profile and mortality rates of scleroderma renal crisis in Italy.
Codullo V; Cavazzana I; Bonino C; Alpini C; Cavagna L; Cozzi F; Del Papa N; Franceschini F; Guiducci S; Morozzi G; Ruffatti A; Ferri C; Giacomelli R; Matucci-Cerinic M; Valentini G; Montecucco C
J Rheumatol; 2009 Jul; 36(7):1464-9. PubMed ID: 19487262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
